NanoVibronix (NAOV) Revenue & Revenue Breakdown
NanoVibronix Revenue Highlights
Latest Revenue (Y)
$2.28M
Latest Revenue (Q)
$494.00K
Main Geography (Y)
Other Country
NanoVibronix Revenue by Period
NanoVibronix Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.28M | 203.59% |
| 2022-12-31 | $752.00K | -55.63% |
| 2021-12-31 | $1.70M | 172.07% |
| 2020-12-31 | $623.00K | 17.55% |
| 2019-12-31 | $530.00K | 66.67% |
| 2018-12-31 | $318.00K | 33.05% |
| 2017-12-31 | $239.00K | 4.37% |
| 2016-12-31 | $229.00K | 55.78% |
| 2015-12-31 | $147.00K | -27.59% |
| 2014-12-31 | $203.00K | -3.79% |
| 2013-12-31 | $211.00K | 27.11% |
| 2012-12-31 | $166.00K | 76.60% |
| 2011-12-31 | $94.00K | - |
NanoVibronix generated $2.28M in revenue during NA 2023, up 203.59% compared to the previous quarter, and up 717.92% compared to the same period a year ago.
NanoVibronix Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $494.00K | -51.80% |
| 2025-03-31 | $1.02M | 130.86% |
| 2024-12-31 | $444.00K | 18.09% |
| 2024-09-30 | $376.00K | -53.98% |
| 2024-06-30 | $817.00K | -11.29% |
| 2024-03-31 | $921.00K | -21.75% |
| 2023-12-31 | $1.18M | 156.99% |
| 2023-09-30 | $458.00K | 55.78% |
| 2023-06-30 | $294.00K | -16.95% |
| 2023-03-31 | $354.00K | -447.06% |
| 2022-12-31 | $-102.00K | -205.15% |
| 2022-09-30 | $97.00K | -80.00% |
| 2022-06-30 | $485.00K | 78.31% |
| 2022-03-31 | $272.00K | -64.90% |
| 2021-12-31 | $775.00K | 55.31% |
| 2021-09-30 | $499.00K | 56.92% |
| 2021-06-30 | $318.00K | 208.74% |
| 2021-03-31 | $103.00K | 14.44% |
| 2020-12-31 | $90.00K | -40.00% |
| 2020-09-30 | $150.00K | -44.24% |
| 2020-06-30 | $269.00K | 135.96% |
| 2020-03-31 | $114.00K | 31.03% |
| 2019-12-31 | $87.00K | -13.86% |
| 2019-09-30 | $101.00K | -61.60% |
| 2019-06-30 | $263.00K | 232.91% |
| 2019-03-31 | $79.00K | 46.30% |
| 2018-12-31 | $54.00K | - |
| 2018-09-30 | $54.00K | -59.09% |
| 2018-06-30 | $132.00K | 71.43% |
| 2018-03-31 | $77.00K | 10.00% |
| 2017-12-31 | $70.00K | 7.69% |
| 2017-09-30 | $65.00K | 25.00% |
| 2017-06-30 | $52.00K | - |
| 2017-03-31 | $52.00K | 6.12% |
| 2016-12-31 | $49.00K | -19.67% |
| 2016-09-30 | $61.00K | -1.61% |
| 2016-06-30 | $62.00K | 8.77% |
| 2016-03-31 | $57.00K | 46.15% |
| 2015-12-31 | $39.00K | -2.50% |
| 2015-09-30 | $40.00K | 2.56% |
| 2015-06-30 | $39.00K | 34.48% |
| 2015-03-31 | $29.00K | -44.23% |
| 2014-12-31 | $52.00K | 108.00% |
| 2014-09-30 | $25.00K | -60.94% |
| 2014-06-30 | $64.00K | 3.23% |
| 2014-03-31 | $62.00K | 675.00% |
| 2013-12-31 | $8.00K | -84.00% |
| 2013-09-30 | $50.00K | 47.06% |
| 2013-03-31 | $34.00K | -40.35% |
| 2012-12-31 | $57.00K | 42.50% |
| 2012-09-30 | $40.00K | - |
NanoVibronix generated $494.00K in revenue during Q2 2025, up -51.80% compared to the previous quarter, and up 53.64% compared to the same period a year ago.
NanoVibronix Revenue Breakdown
NanoVibronix Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| NEW ZEALAND | $12.00K | - | - | - | - |
| ISRAEL | $4.00K | $1.00M | $5.00K | - | - |
| Europe | $17.00K | $101.00M | $25.00K | $18.00K | $147.00K |
| AUSTRALIA | $29.00K | $19.00M | $9.00K | - | - |
| Other Country | $46.00K | $5.00K | - | - | - |
| UNITED STATES | - | $2.16B | $710.00K | $1.63M | - |
| INDIA | - | - | $3.00K | - | - |
| Other country | - | - | - | $45.00K | - |
| Israel | - | - | - | - | $3.00K |
| Other | - | - | - | - | $5.00K |
| United States | - | - | - | - | $467.00K |
| India | - | - | - | - | $1.00K |
Latest
NanoVibronix's latest annual revenue breakdown by geography, as of Dec 24: Other Country (42.59%), AUSTRALIA (26.85%), Europe (15.74%), NEW ZEALAND (11.11%), and ISRAEL (3.70%).
Quarterly Revenue by Country
| Country | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Europe | $8.00 | $9.00K | $9.00K | $8.00K | $100.98M | $19.00K | $12.00K | $6.00K | $7.00K | $3.00K | $4.00K | $10.00K | $1.00K | $10.00K | $17.00K | - | - | - | - | - |
| Australia/New Zealand | $20.00 | $7.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| UNITED STATES | $462.00K | $986.00K | $349.00K | $794.00K | $905.00M | $2.16B | $445.00K | $282.00K | $309.00K | $-118.00K | $90.00K | $476.00K | $231.00K | $753.00K | $490.00K | $292.00K | - | - | - | - |
| Other Country | $4.00 | $11.00K | - | $12.00M | $11.00K | $12.00K | $12.00K | - | - | - | - | - | - | - | - | - | - | - | - | - |
| AUSTRALIA | - | $19.00K | - | $8.00K | $4.00M | $18.98M | $2.00K | $13.00K | - | - | - | - | - | - | - | - | - | - | - | - |
| Other | - | - | - | $12.00K | $15.00K | $23.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asia | - | - | - | - | - | - | - | - | - | $1.00K | $1.00K | $9.00K | - | - | - | - | - | - | - | - |
| NEW ZEALAND | - | - | - | - | - | - | - | - | - | - | - | $1.00K | $3.00K | $2.00K | $3.00K | $3.00K | - | - | - | - |
| ISRAEL | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.00K | $2.00K | $1.00K | - | - | - |
| CANADA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $12.00K | - | - | - |
| Israel | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.00K | - | $1.00K |
| New Zealand | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $9.00K | - | - |
| United States | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $92.00K | $76.00K | $130.00K |
| India | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-1.00K | $2.00K |
Latest
NanoVibronix's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (99.99%), Australia/New Zealand (0.00%), Europe (0.00%), and Other Country (0.00%).
NanoVibronix Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| VERO | Venus Concept | $64.83M | $13.64M |
| NAOV | NanoVibronix | $2.28M | $494.00K |
| MOVE | Movano | $1.01M | $103.00K |
| ACON | Aclarion | $45.72K | $18.99K |
| HSCS | HeartSciences | $18.60K | $1.90M |
| BBLG | Bone Biologics | - | - |
| CNSP | CNS Pharmaceuticals | - | - |
| BJDX | Bluejay Diagnostics | - | - |
| AMIX | Autonomix Medical | - | - |
| NDRA | ENDRA Life Sciences | - | - |
| GRI | GRI Bio | - | - |